Intercept Pharmaceuticals
Ralph Saraceno is an experienced sales professional in the pharmaceutical industry, currently serving as a Territory Business Manager for Rare Disease at Intercept Pharmaceuticals, focusing on primary biliary cholangitis. Prior positions include Senior Oncology Sales Representative at Helsinn Therapeutics (U.S.), where responsibilities included promoting Valchlor for Mycosis Fungoides Cutaneous T-Cell Lymphoma and achieving notable sales rankings. Additionally, Ralph has a strong record at Helsinn Therapeutics, ranking #1 nationally in 2021 while selling Truseltiq and Valchlor, and has experience at Cumberland Pharmaceuticals and Eisai US, where Ralph served as National Neurology Field Trainer and achieved sales goals for epilepsy treatments. Ralph began a career in sales at Pfizer, covering various therapeutic areas and enhancing healthcare outcomes. Ralph holds a Bachelor of Arts in Accounting from Rutgers University - Camden.
This person is not in any teams
This person is not in any offices
Intercept Pharmaceuticals
1 followers
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.